WASHINGTON Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications
"Novo Nordisk stands behind the safety and efficacy of our FDA-approved semaglutide medicines when used as indicated and when taken under the care of a licensed healthcare professional." The company also said it cannot "validate the safety or effectiveness of compounded products" with semaglutide that are not Novo Nordisk-branded products
References Coskun, T., Sloop, K.W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K.B., Cui, X., Briere, D.A., Cabrera, O., Roell, W.C., Kuchibhotla, U., Moyers, J.S., Benson, C.T., Gimeno, R.E., DAlessio, D.A., & Haupt, A
Results based on a randomized 12-week human clinical study
Weight Loss Plan Includes Semaglutide (Generic Ozempic) FAQ'S Everything you need to know about DNM Medical Weight Loss Program What is the Semaglutide
Trials show ~1522% average body-weight loss